Home Cart Sign in  
Chemical Structure| 200484-11-3 Chemical Structure| 200484-11-3

Structure of CHS-828
CAS No.: 200484-11-3

Chemical Structure| 200484-11-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GMX1778 is a competitive NAMPT (nicotinamide phosphoribosyltransferase) inhibitor.

Synonyms: GMX1778

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CHS-828

CAS No. :200484-11-3
Formula : C19H22ClN5O
M.W : 371.86
SMILES Code : N#CN/C(NCCCCCCOC1=CC=C(Cl)C=C1)=N\C2=CC=NC=C2
Synonyms :
GMX1778
MDL No. :MFCD03700766
InChI Key :BOIPLTNGIAPDBY-UHFFFAOYSA-N
Pubchem ID :148198

Safety of CHS-828

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • NAMPT

    NAMPT, Kd:120 nM

    NAMPT, IC50:<25 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
NYH 1.7 ± 1.2 nM 3 weeks To determine the cytotoxicity of CHS-828 on NYH cells BMC Cancer. 2010 Dec 12;10:677
HCT-116 12.2 ± 7.4 nM 3 weeks To determine the cytotoxicity of CHS-828 on HCT-116 cells BMC Cancer. 2010 Dec 12;10:677
PC-3 8.8 ± 8.4 nM 3 weeks To determine the cytotoxicity of CHS-828 on PC-3 cells BMC Cancer. 2010 Dec 12;10:677
human breast cancer (MCF) 18 nM Evaluation of CHS-828 cytotoxicity against MCF cells, showing an IC50 value of 18 nM. Molecules. 2015 Jun 23;20(6):11535-53
nasopharyngeal carcinoma (HONE1) 15 nM Evaluation of CHS-828 cytotoxicity against HONE1 cells, showing an IC50 value of 15 nM. Molecules. 2015 Jun 23;20(6):11535-53
human liver cancer (HEPG2) 1245 nM Evaluation of CHS-828 cytotoxicity against HEPG2 cells, showing an IC50 value of 1245 nM. Molecules. 2015 Jun 23;20(6):11535-53
human liver cancer (HA22T) 2067 nM Evaluation of CHS-828 cytotoxicity against HA22T cells, showing an IC50 value of 2067 nM. Molecules. 2015 Jun 23;20(6):11535-53
human colon cancer (DLD1) 2315 nM Evaluation of CHS-828 cytotoxicity against DLD1 cells, showing an IC50 value of 2315 nM. Molecules. 2015 Jun 23;20(6):11535-53
human gastric cancer (NUGC) 25 nM Evaluation of CHS-828 cytotoxicity against NUGC cells, showing an IC50 value of 25 nM. Molecules. 2015 Jun 23;20(6):11535-53
CCD-1064SK fibroblasts >10 μM 72 h Determine the IC50 value of CHS-828 for fibroblasts, showing no significant toxicity after 72 h of exposure. J Transl Med. 2009 Mar 12;7:16
hTERT-BCE endothelial cells 50–100 nM 72 h Determine the IC50 value of CHS-828 for endothelial cells, showing toxicity after 72 h of exposure. J Transl Med. 2009 Mar 12;7:16
SK-N-SH cells 2–5 nM 72 h Determine the IC50 value of CHS-828 for SK-N-SH cells, showing toxicity after 72 h of exposure. J Transl Med. 2009 Mar 12;7:16
SH-SY5Y cells 2–5 nM 72 h Determine the IC50 value of CHS-828 for SH-SY5Y cells, showing toxicity after 72 h of exposure. J Transl Med. 2009 Mar 12;7:16
IMR-32 cells 0.2-0.5 nM 72 h Evaluate the cytotoxic effects of CHS-828 on neuroblastoma cells, showing significant cell death after 72 h of exposure. J Transl Med. 2009 Mar 12;7:16
human lymphoma cell line U-937 GTB 1.0 μM 0-48 h To study the cytotoxic synergy and apoptosis inhibition of CHS-828 in combination with etoposide. Results showed that short pre-exposure (0-12 h) enhanced etoposide-induced caspase activation, while longer pre-exposure (18-48 h) inhibited both caspase activation and apoptotic morphology. Br J Pharmacol. 2002 Oct;137(4):568-73

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Eucalyptus globulus Eucalyptus globulus trees Foliar spray 250 μM Initially treated twice, then once a week after two weeks, four times in total, for 4 months CHS-828 inhibited NAD(P)H synthesis, thereby inhibiting the OC kappa-induced increase in total essential oils and terpenoid metabolism reprogramming. Molecules. 2014 Jun 5;19(6):7356-67
SCID mice Orthotopic neuroblastoma model Oral 20 mg/kg Once daily for 10 or 30 days Evaluate the therapeutic effects of CHS-828 on orthotopic neuroblastoma, showing significant tumor volume reduction, decreased metastasis, and no observable toxicity. J Transl Med. 2009 Mar 12;7:16

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.69mL

0.54mL

0.27mL

13.45mL

2.69mL

1.34mL

26.89mL

5.38mL

2.69mL

References

 

Historical Records

Categories